<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01019499</url>
  </required_header>
  <id_info>
    <org_study_id>NPHIKTL</org_study_id>
    <nct_id>NCT01019499</nct_id>
  </id_info>
  <brief_title>The Effect of Berry Consumption on Indicators of Cardiovascular Disease Risk</brief_title>
  <official_title>The Effect of Berry Consumption on Indicators of Cardiovascular Disease Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute for Health and Welfare, Finland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agrifood Research Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Finnish Funding Agency for Technology and Innovation (TEKES)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academy of Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute for Health and Welfare, Finland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effects of berry consumption on indicators of
      cardiovascular disease risk (blood pressure, cardiovascular biomarkers, nutrigenomics).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study has a randomized crossover design. It consists of two 8-wk dietary treatments, with
      no washout period between periods. The participants are blinded to treatments. The subjects
      are randomly assigned to either a berry diet or a control diet which they follow for 8 weeks.
      After that they are crossed over to the other diet for another 8 weeks. The main visits to
      the study site are at baseline and after 8 and 16 weeks (for blood pressure measurement/
      cardiovascular measurements and sample collection). The additional visits are at 4 and 12 wk;
      these visits are for compliance checks, meeting the study nurse and receiving the study
      products. The subjects are asked to maintain their normal dietary and lifestyle habits, as
      well as to keep alcohol intake and physical activity constant during the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2009</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>0, 8 and 16 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PFA-100 measurement</measure>
    <time_frame>0, 8 and 16 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>biomarkers of cardiovascular disease risk</measure>
    <time_frame>0, 8 and 16 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">37</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Platelet Function</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>berry products</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Berry products</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control products</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control products</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>berry products</intervention_name>
    <description>effects of berry consumption on cardiovascular indicators
two portions daily</description>
    <arm_group_label>berry products</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control products</intervention_name>
    <description>two portions daily</description>
    <arm_group_label>control products</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  mild hypertension (systolic blood pressure 130-159 mmHg, diastolic blood pressure
             85-99 mmHg)

        Exclusion Criteria:

          -  smoking

          -  regular use of medications (except hormone replacement therapy) or dietary supplements

          -  intestinal disorders

          -  obesity (BMI&gt; 35 kg/m2)

          -  vegetarianism

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antti Jula, DR.</last_name>
    <role>Study Director</role>
    <affiliation>National Institute for Health and Welfare, Finland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institute for Health and Welfare</name>
      <address>
        <city>Helsinki</city>
        <zip>00300</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>National Institute for Health and Welfare</name>
      <address>
        <city>Turku</city>
        <zip>20720</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2009</study_first_submitted>
  <study_first_submitted_qc>November 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2009</study_first_posted>
  <last_update_submitted>June 18, 2010</last_update_submitted>
  <last_update_submitted_qc>June 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2010</last_update_posted>
  <responsible_party>
    <name_title>Iris Erlund, Senior researcher</name_title>
    <organization>National Institute for Health and Welfare</organization>
  </responsible_party>
  <keyword>human</keyword>
  <keyword>intervention</keyword>
  <keyword>blood pressure</keyword>
  <keyword>cardiovascular risk factors</keyword>
  <keyword>polyphenols</keyword>
  <keyword>bioavailability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

